InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
0.00%
)
US TECH 100
19,152.00
(
-0.29%
)
Dow Jones
39,150.33
(
0.00%
)
Brent Oil
84.74
(
0.85%
)
Bitcoin
61,262.12
(
-3.00%
)
Post# of 158400
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

PG

Send PM Follow Ignore
Followers 105
Posts 871
Boards Moderated 0
Alias Born 03/27/2013

PG

Re: 1~Eye~Jack!! post# 90507

Tuesday, 08/13/2013 11:30:52 AM

Tuesday, August 13, 2013 11:30:52 AM

Post# of 158400
Contacting the SEC will only create more headaches and perhaps cause delays in the current processes the company is trying to complete.

They will not intervene; there is no legal justification for it. And if they were to entertain pursuing something against the company (only to later find FOR the company) the money that will be required to pay for legal counsel will be money that can be used toward seeing the treatments come to fruition.

Now, do we really want to create more issue with the state of the PPS by attempting to have the SEC scrutinize BMSN? I think not.

If you are opposed to the increase to pay for the science and all the fees associated with BMSN securing the rights, how do you propose the company pays for it? Please, spell it out for us with specifics.


BMSN

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up